MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Europe
*Europe: Regions
*Western Europe
Switzerland
*Industry: Switzerland
Galencia
Finance & Acquisition: Galencia
Relypsa (Nasdaq - RLYP)
Organization & Developments: Relypsa
Parents
Relypsa (Nasdaq - RLYP)
Children
2010: Relypsa - Top 15 Biotech VC Deals of 2010
2016: A Rebuttal To A Short Thesis On Relypsa - Relypsa, Inc. (NASDAQ:RLYP)
2016: Relypsa: A Home Run Or A Strike Out Kind Of Stock? - Relypsa, Inc. (NASDAQ:RLYP)
2016: Relypsa: Buyout Appears Imminent - Relypsa, Inc. (NASDAQ:RLYP)
2016: Relypsa: Nothing But Good News For The Company - Relypsa, Inc. (NASDAQ:RLYP)
2016: Relypsa: So Far, So Good - Relypsa, Inc. (NASDAQ:RLYP)
2016: Who Will Buy Relypsa, And At What Price? - Relypsa, Inc. (NASDAQ:RLYP)
Relypsa's lead compound is RLY5016, which the company's site describes as a "high capacity cation binder for the management of hyperkalemia in congestive heart failure (CHF) and chronic kidney disease (CKD) patients."
Jumps
*Key People: Relypsa
Finance & Acquisitions: Relypsa